Other nephrology experience

  • Payer objection handlers to support treatment in secondary hyperparathyroidism (SHPT)
  • Consultation on an FDA PRO claim in nephrology
  • COA strategies to complement a biology and renal/fibrotic portfolio
  • Qualitative literature and instrument review in atypical Haemolytic Uremic Syndrome (aHUS)

Related categories

Experience,  Nephrology,  Therapeutic area